Registration
THORN RUN PARTNERS for THE BIOSIMILARS FORUM
Firm
Client
Income
—
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Medicare reimbursement issues; FDA regulations of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON New | — |
| STUART CHAPMAN New | — |
| ALEX DELPIZZO New | — |
Medical/Disease Research/Clinical Labs MED
Medicare reimbursement issues; FDA regulations of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON New | — |
| STUART CHAPMAN New | — |
| ALEX DELPIZZO New | — |
Accounting ACC
Medicare reimbursement issues; FDA regulations of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON New | — |
| STUART CHAPMAN New | — |
| ALEX DELPIZZO New | — |
Health Issues HCR
Medicare reimbursement issues; FDA regulations of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON New | — |
| STUART CHAPMAN New | — |
| ALEX DELPIZZO New | — |
Medicare/Medicaid MMM
Medicare reimbursement issues; FDA regulations of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON New | — |
| STUART CHAPMAN New | — |
| ALEX DELPIZZO New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM GMBH | Germany | Germany | 100.0% | — |
| MERCK KGAA | Germany | Germany | 100.0% | — |
| FRESENIUS KABI AG | Germany | Germany | 100.0% | — |
| NOVARTIS AG | Switzerland | Switzerland | 100.0% | — |
| SAMSUNG BIOEPIS | South Korea | South Korea | 100.0% | — |
| TEVA PHARMACEUTICAL INDUSTRIES LTD. | Israel | Israel | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.